• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Anastrozole Teva
    / Teva

    Active Ingredient

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 X 1 mg

    partial basket chart 79385 9332

    Related information


    See prescribing information for full details.


    Treatment of advanced breast cancer in postmenopausal women. Efficacy has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer.Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.


    Pre-menopausal women. Pregnancy, lactation. Severe renal impairment.

    Drug interactions

    Estrogen-containing therapies, concurrent tamoxifen therapy.
    Please contact distributing company for full details.

    Teva Pharmaceutical Industries Ltd, Israel